Clinical Trials Directory

Trials / Completed

CompletedNCT05910242

Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH)

Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Yi Yang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning in the treatment of essential hypertension.

Detailed description

Current studies have shown that remote ischemic conditioning can improve vascular endothelial function, inhibit sympathetic nervous system activity and regulate immune and inflammatory reactions. Thus it may exert anti-hypertensive effects through multiple mechanisms. The purpose of this study is to investigate the efficacy and safety of remote ischemic conditioning on blood pressure patients with essential hypertension.

Conditions

Interventions

TypeNameDescription
PROCEDURERemote ischemic conditioningRemote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mm Hg.
PROCEDURESham remote ischemic conditioningSham-RIC is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mm Hg.

Timeline

Start date
2023-06-20
Primary completion
2024-03-06
Completion
2024-03-06
First posted
2023-06-18
Last updated
2025-06-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05910242. Inclusion in this directory is not an endorsement.